Cadbury's chocolate-coated deal


Cadbury Schweppes's soft drinks division has hogged the headlines for the company this year. January's pounds 1.1bn deal to buy the remainder of Dr Pepper transformed the group's drinks interests and made Cadbury a credible number three in the US market behind Coca-Cola and Pepsi.

But while the soft drinks market offers the more spectacular opportunities, the confectionery division offers steady growth, too. Yesterday's pounds 108m deal to buy the Canadian business, Neilson Cadbury, underlines the group's strategy to hoist itself up the worldwide confectionery league. The top places are held by Nestle, Mars and then Philip Morris which owns Jacob Suchard. Cadbury is in the tier below along with Hershey of the US.

Cadbury may have a wish list of big targets such as Ferrero of Italy or Lindt of Switzerland. But if these prove elusive it can still put on muscle with a series of smaller deals like this one in Canada. It is growing organically by investing in younger markets such as Russia, Poland and Argentina.

Cadbury already has Canadian links through its Trebor division but with this deal it is buying back an old cast-off spruced up under different owners.

Cadbury sold its Canadian interests to Neilson in 1987 but retained a royalty agreement. It bailed out then because the market was ultra-competitive and the business was performing poorly. It is now buying back a bigger, stronger business that has Cadbury and Neilson product ranges and an improved manufacturing system with a lower cost base.

There is solid logic to this deal. In June, Cadbury acquired Allan Candy, one of Canada's biggest confectionery companies. With the Neilson business bolted on, Cadbury will be market leader in Canadian confectionery ahead of Nestle and Mars. The market is still competitive as last year's profits of pounds 5m on sales of pounds 109m testify. But there should be benefits from running the Allan Candy and Neilson businesses together.

The deal adds to Cadbury Schweppes's debt mountain which stood at pounds 1.4bn at the half-year stage in September, giving gearing of 100 per cent. Cadbury says it is using debt to pay for the deal, though a share placing cannot be ruled out.

Cadbury Schweppes shares have enjoyed strong growth this year rising by more than 50 per cent to 547p, up 0.5p yesterday.

That growth has put the shares on a forward rating of over 16, a premium to the market. But with analysts forecasting profits of pounds 525m this year and pounds 625 next year the shares are a decent hold.

Chiroscience in Medeva tie-up

Shares in the "biotech babes" had done well this year even before British Biotech's were sent soaring by last month's announcement of a potential breakthrough in the treatment of cancer. Chiroscience, a leader in so-called chiral chemistry, is no exception, but the roller-coaster nature of the sector was well-illustrated by yesterday's announcement of a co-development deal with Medeva. Having more than tripled from around 100p this year, the shares fell back 25p to 339p on the news.

The market did not have very much to go on, as neither company would even reveal which drug was involved or which side it belonged to. But the rationale behind the fall in the shares was presumably that Chiroscience is about to give something away by letting Medeva in on the act.

That looks wide of the mark. Yesterday's deal is most likely to relate to methylphenidate, Medeva's controversial treatment for hyperactivity in children, known as "attention deficit disorder" in the US. Facing the prospect of competition in 1997 from Johnson Matthey, which is developing a rival generic version of the drug, Medeva is no doubt looking to add some bells and whistles to its product, which is presumably where Chiroscience's chiral speciality comes in.

This branch of chemistry studies the ability to isolate isomers of existing drugs, making them purer and potentially less prone to causing side-effects. Applying that science to methylphenidate could allow Medeva to clean up in what could be a pounds 220m market in the US. A 10 per cent royalty on those sales would net Chiroscience potentially pounds 20m. Even if the new drug is no more than a line extension of the existing drug, it could pull in more royalties than Chiroscience's entire pounds 1.71m turnover for last year.

There should be plenty of further news flow to keep investors happy in the new year. D3967, a treatment for breast cancer, goes into clinical trials in February, when there should also be further details of the Medeva deal. But, "burning" cash at the rate of pounds 1.1m a month, Chiroscience will need to raise more money soon as its cash balances last August were only pounds 21m. Given Yamaichi's net asset value estimate of 520p a share, the company should have little difficulty raising the cash, but the shares remain speculative.

Kunick a good

recovery bet

Kunick yesterday laid to rest the joke that the 10p tokens paid out of its Bell Fruit gaming machines were a more valuable currency than the company's shares. Sent reeling by the recession, Kunick is now one of the least risky recovery plays in the leisure sector.

Profits before tax for the year to 30 September, announced yesterday, grew from pounds 7.1m to pounds 8.3m - a stark contrast to the river of red ink that flowed from the accounts three years ago. Despite the continuing impact of the National Lottery, further, solid growth is on the cards this year, with deregulation allowing fruit machines into betting shops. If everything goes to plan there will upwards of 12,000 fruit machines in bookies this time next year.

If Kunick can lay claim to 25 per cent of that market, through deals with the likes of Ladbroke, the rewards will be handsome. Analysts reckon 3,000 machines could equate to pounds 1m a year of profits.

On top of gaming, Kunick has another nice little earner in the form of a 50 per cent share in Finagest, the nursing homes business which could be floated off as early as 1997. With luck that will make up for a sharp downturn in consumer spending in France which has hit that country's operations hard.

All told, the existing businesses, a joint venture with Allied Domecq to develop 20,000 sq ft leisure complexes and a move into the management of local authority leisure facilities should see group taxable profits climb to pounds 10.5m this year.

The shares have soared 70 per cent this year to almost 24p, but still look to have a way to run. Prospective earnings per share of 1.67p give a p/e of 14.2, and a dividend of 0.7p to follow this year's 0.6p gives a gross yield of 3.7 per cent. Good value.

Start your day with The Independent, sign up for daily news emails
England's women celebrate after their 3rd place play-off win against Germany
Women's World CupFara Williams converts penalty to secure victory and bronze medals
Arts and Entertainment
Ricardo by Edward Sutcliffe, 2014
artPortraits of LA cricketers from notorious suburb go on display
newsHillary Clinton comments on viral Humans of New York photo of gay teenager
Arts and Entertainment
The gang rape scene in the Royal Opera’s production of Gioachino Rossini’s Guillaume Tell has caused huge controversy
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

Day In a Page

The Greek referendum exposes a gaping hole at the heart of the European Union – its distinct lack of any genuine popular legitimacy

Gaping hole at the heart of the European Union

Treatment of Greece has shown up a lack of genuine legitimacy
Number of young homeless in Britain 'more than three times the official figures'

'Everything changed when I went to the hostel'

Number of young homeless people in Britain is 'more than three times the official figures'
Compton Cricket Club

Compton Cricket Club

Portraits of LA cricketers from notorious suburb to be displayed in London
London now the global money-laundering centre for the drug trade, says crime expert

Wlecome to London, drug money-laundering centre for the world

'Mexico is its heart and London is its head'
The Buddhist temple minutes from Centre Court that helps a winner keep on winning

The Buddhist temple minutes from Centre Court

It helps a winner keep on winning
Is this the future of flying: battery-powered planes made of plastic, and without flight decks?

Is this the future of flying?

Battery-powered planes made of plastic, and without flight decks
Isis are barbarians – but the Caliphate is a dream at the heart of all Muslim traditions

Isis are barbarians

but the Caliphate is an ancient Muslim ideal
The Brink's-Mat curse strikes again: three tons of stolen gold that brought only grief

Curse of Brink's Mat strikes again

Death of John 'Goldfinger' Palmer the latest killing related to 1983 heist
Greece debt crisis: 'The ministers talk to us about miracles' – why Greeks are cynical ahead of the bailout referendum

'The ministers talk to us about miracles'

Why Greeks are cynical ahead of the bailout referendum
Call of the wild: How science is learning to decode the way animals communicate

Call of the wild

How science is learning to decode the way animals communicate
Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

'The economic collapse has happened. What is at risk now is democracy...'

If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
The science of swearing: What lies behind the use of four-letter words?

The science of swearing

What lies behind the use of four-letter words?
The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

The Real Stories of Migrant Britain

Clive fled from Zimbabwe - now it won’t have him back
Africa on the menu: Three foodie friends want to popularise dishes from the continent

Africa on the menu

Three foodie friends want to popularise dishes from the hot new continent
Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

Who will fill Donna Karan's boots?

The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'